1996
DOI: 10.1002/eji.1830260210
|View full text |Cite
|
Sign up to set email alerts
|

An HLA‐B35‐restricted epitope modified at an anchor residue results in an antagonist peptide

Abstract: Peptides associated with HLA-B35 commonly have a proline or occasionally a serine residue in the P2 anchor position of the peptide, with a tyrosine at the C terminus. Based on this motif, we identified an octamer epitope from influenza A matrix protein which is presented by HLA-B35. The requirements for MHC binding and T cell receptor contact have been analyzed using analogs of this peptide with substitutions at positions 1, 2, 4, 7 and 8. The natural epitope contains a serine residue at P2 of the peptide. Sub… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
20
0

Year Published

1997
1997
2009
2009

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 42 publications
(21 citation statements)
references
References 36 publications
1
20
0
Order By: Relevance
“…The low binding affinity of M1 peptides is likely because of their size and/or lack of the 2 characteristic B*0702 anchor residues. This is consistent with reports of other influenza matrix ligands that lack a characteristic class I anchor residue and exhibit a low binding affinity (15). With the exception of the matrix peptides, the ligands reported here are consistent in size, binding affinity, and sequence with previously reported B*0702 epitopes of viral and human origin (9).…”
Section: Comparative Mass Spectrometry Reveals 7 Influenza Hla B*0702supporting
confidence: 91%
“…The low binding affinity of M1 peptides is likely because of their size and/or lack of the 2 characteristic B*0702 anchor residues. This is consistent with reports of other influenza matrix ligands that lack a characteristic class I anchor residue and exhibit a low binding affinity (15). With the exception of the matrix peptides, the ligands reported here are consistent in size, binding affinity, and sequence with previously reported B*0702 epitopes of viral and human origin (9).…”
Section: Comparative Mass Spectrometry Reveals 7 Influenza Hla B*0702supporting
confidence: 91%
“…Of special interest, HLA-B‫-1053ء‬positive cells infected with influenza virus A/NL/95-NP M426I were poorly recognized by NP 418-426 -specific T-cell clones. Since the NP M426I mutant epitope retained its capacity to bind to HLA-B‫,1053ء‬ it may have undergone conformational changes in T-cell receptor contact residues, preventing recognition by CTL, as has been described previously for another HLA-B‫-1053ء‬restricted epitope (15). Conservative amino acid substitutions at the anchor residues of the epitopes PB1 591-599 (VSDGGPNLY), NP [44][45][46][47][48][49][50][51][52] (CTELKLSDY), and NP 174-184 (RRSGAAGAAVK) also affected viral fitness.…”
Section: Discussionmentioning
confidence: 77%
“…The cultures were restimulated after 14 d using autologous BCLs pulsed with the appropriate peptides. Antigen-specific CD4 + and CD8 + T cell clones were established by limiting dilution of the T cell lines as described previously (66).…”
Section: Methodsmentioning
confidence: 99%